Prevalence of Endolymphatic Hydrops With a Hitory of Congenital Cytomegalovirus Infection

NCT05229744 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2026-01-06

No results posted yet for this study

Summary

The management of patients with a history of congenital CMV infection (whether symptomatic or asymptomatic at birth) is modeled on their usual management.

Conditions

  • Endolymphatic Hydrops

Interventions

DEVICE

sequence MRI 3D FLAIR

Participation in this research entails the addition of an MRI sequence and an injection of contrast product (Gadovist®): \- 3D FLAIR MRI sequence dedicated to the exploration of the inner ear, lasting 6min30s, performed 4 hours after the initial injection of contrast product

Sponsors & Collaborators

  • Fondation Ophtalmologique Adolphe de Rothschild

    lead NETWORK

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-15
Primary Completion
2025-04-22
Completion
2025-04-22

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05229744 on ClinicalTrials.gov